News

Filter

Current filters:

Biogen Idecocrelizumab

US FDA approves Genentech/Roche’s Herceptin for HER2-positive metastatic stomach cancer; Roche amends deal with Biogen

22-10-2010

US biotech giant Genentech, part of Swiss drug major Roche (ROG: VX), says the US Food and Drug Administration…

Biogen IdecGenentechHerceptinLicensingNorth AmericaocrelizumabOncologyPharmaceuticalRegulationRoche

Roche/Biogen drop development of ocrelizumab in rheumatoid arthritis

19-05-2010

In an announcement that probably comes as no surprise, Swiss drug major Roche and partner USA-based Biogen…

Anti-Arthritics/RheumaticsBiogen IdecocrelizumabPharmaceuticalResearchRoche

COMPANY SPOTLIGHT

Menarini

Back to top